Related Experiment Videos
Genetic aspects of miscarriage.
1Centre for Reproductive Medicine, Academic Medical Centre, Amsterdam, 1100 DE, TheNetherlands.
Summary
Fetal chromosome abnormalities cause half of early pregnancy losses, primarily numerical types. Structural abnormalities may be inherited, necessitating prenatal diagnosis for at-risk couples.
Area of Science:
- Reproductive genetics
- Fetal medicine
- Clinical cytogenetics
Background:
- Fetal chromosome abnormalities contribute significantly to first-trimester pregnancy loss.
- Numerical abnormalities are most common (86%), followed by structural abnormalities (6%) and mosaicism (8%).
- Recurrence risk for numerical abnormalities is low, limiting routine karyotyping of miscarriage tissue.
Purpose of the Study:
- To review the role of fetal chromosome abnormalities in early pregnancy loss.
- To discuss diagnostic techniques for identifying chromosomal abnormalities.
- To highlight the importance of parental carrier screening for structural abnormalities.
Main Methods:
- Review of conventional laboratory techniques: tissue culturing, karyotyping, chorionic villi sampling.
- Description of advanced techniques: fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH).
- Discussion of genetic mechanisms including single-gene defects, uniparental disomy, imprinting, and multifactorial disorders.
Main Results:
- Half of structural abnormalities may stem from parental balanced translocations or inversions.
- Parental carriership of balanced structural abnormalities is found in 4-6% of recurrent miscarriage cases.
- Inherited unbalanced structural abnormalities can lead to congenital malformations and intellectual disability.
Conclusions:
- Prenatal diagnosis is recommended for pregnancies where parental balanced structural chromosome abnormalities are identified.
- Further research is needed to clarify the role of other genetic mechanisms in miscarriage.
- Routine karyotyping of fetal material for numerical abnormalities in miscarriages may not be clinically indicated.